February 22, 2018 / 6:52 AM / 3 months ago

BRIEF-Recipharm Q4 EBITDA At SEK 226 Million

Feb 22 (Reuters) - RECIPHARM AB (PUBL):

* Q4 NET SALES SEK 1.40 BILLION VERSUS SEK 1.33 BILLION YEAR AGO

* Q4 EBITDA SEK 226 MILLION VERSUS SEK 229 MILLION YEAR AGO

* PROPOSES NO DIVIDEND FOR 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below